Glycomics: From glycobiology to diagnostics and therapeutics

Drug News and Perspectives

Volumn 19, Issue 3, 2006, Pages 163-172

  Bedford, Colin ^a   Cass, Tony ^a   François, Irene ^a   Harding, Stephen ^a  

^a ROYAL SOCIETY OF CHEMISTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYNOJIRIMYCIN; BINDING PROTEIN; CARBOHYDRATE; CASTANOSPERMINE; GLINUS OPPOSITIFOLIUS; GLYCAN; GLYCOLIPID; IMMUNOMODULATING AGENT; MIGLUSTAT; MNLP 462A; OLIGOSACCHARIDE; PLANT EXTRACT; PLANTAGO MAJOR EXTRACT; POLYSACCHARIDE; QUANTUM DOT; SWAINSONINE; UNCLASSIFIED DRUG;

ARTHRALGIA; BIOTECHNOLOGY; CARBOHYDRATE ANALYSIS; CONFERENCE PAPER; CONTINUING EDUCATION; FEVER; GAUCHER DISEASE; GLYCOBIOLOGY; GLYCOSYLATION; HUMAN; INFLAMMATION; MALARIA; NONHUMAN; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; WOUND;

CARBOHYDRATE METABOLISM, INBORN ERRORS; DRUG DESIGN; DRUG INDUSTRY; GLYCOCONJUGATES; GLYCOSYLATION; HUMANS; MOLECULAR STRUCTURE; POLYSACCHARIDES;

EID: 33745076784     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Blixt, O., Head, S., Mondala, T. et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA 2004, 101: 17033-8.
2. Ritter, C., Quirin, K., Kowarik, M. and Helenius, A. Minor folding defects trigger local modification of glycoproteins by the ER folding sensor GT. EMBO J 2005, 24: 1730-8.
3. Deprez, P., Gautschi, M. and Helenius, A. More than one glycan is needed for ER glucosidase II to allow entry of glycoproteins into the calnexin/calreticulin cycle. Mol Cell 2005, 19: 183-95.
4. Tang, P.W., Gool, H.C., Hardy, M., Lee, Y.C. and Feizi, T. Novel approaches to the study of antigenicities and receptor functions of carbohydrate chains of glycoproteins. Biochem Biophys Res Commun 1985, 132: 474-80.
5. Feizi, T. and Chai, W. Oligosaccharide microarrays to decipher the glyco-code. Nat Rev Mol Cell Biol 2004, 5: 582-8.
6. Palma, A.S., Feizi, T., Stoll, M.S. et al. Ligands for the beta-glucan receptor, dectin-1, assigned using 'designer' microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. J Biol Chem 2006, 281: 5771-9.
7. Chalabi, S., Panico, M., Sutton-Smith, M., Haslam, S.M. et al. Differential O-glycosylation of a conserved domain expressed in murine and human ZP3. Biochemistry 2006, 45: 582-8.
8. Asano, N., Nash, R.J., Molyneux, R.J. and Fleet, G.W.J. Sugar-mimic glycosidase inhibitors: Natural occurrence, biological activity and prospects for therapeutic application. Tetrahedron Asymmetry 2000, 11 : 1645-80.
9. Wallis, R. Structural and functional aspects of complement activation by mannose-binding protein. Immunbiology 2002, 205: 433-45.
10. Snyder, G.A., Colonna, M. and Sun, P.D. The structure of DC-SIGNR with a portion of its repeat domain lends insights to modelling of the receptor tetramer. J Mol Biol 2005, 347: 979-89.
11. Nergard, C.S., Kiyohara, H., Reynolds, J.C. et al. Structures and structure-activity relationships of three mitogenic and complement fixing pectic arabinogalactans from the Malian antiulcer plants Cochlospermum tinctorium A. Rich and Vernonia kotschyana Sch. Bip. Ex Walp. Biomacromolecules 2006, 7: 71-9.
12. Svarovsky, S.A., Szekely, Z. and Barchi, J.J. Jr. Synthesis of gold nanoparticles bearing the Thomsen-Friedenreich disaccharide: A new multivalent presentation of an important tumour antigen. Tetrahedron Asymmetry 2005, 16: 587-98.
13. Halling, P.J., Ulijn, R.V. and Flitsch, S.L. Understanding enzyme actions on immobilised substrates. Curr Opin Biotechnol 2005, 16: 385-92.
14. Fernandas, D.L. Reducing risk in biopharmaceutical production by controlling glycosylation. Eur Biopharm Rev 2004, Winter 2004: 92-7.
15. Fernandes, D.L. Demonstrating comparability of antibody glycosylation during biomanufacturing. Eur Biopharm Rev 2005, Summer 2005: 106-10.
16. Gamblin, D.P., Gamier, P., van Kastteren, S., Oldham, N.J., Fairbanks, A.J. and Davis, B.G. Glyco-SeS: Selenenylsulflde-mediated protein glycoconjugation - A new strategy in posttranslational modification. Angew Chem Int Ed 2004, 43: 828-33.
17. Rudd, P.M., Elliott, T., Cresswell, P., Wilson, I.A. and Dwek, R.A. Glycosylation and the immune system. Science 2005, 291: 2370-6.